---
layout: archive
title: "Articles"
permalink: /publications/
author_profile: true
---
<sup>†</sup>: corresponding author
<br>
<br>
<p><strong>Peer-reviewed Statistical Articles:</strong>
<br>
<br>
<strong>Zhan, T.</strong><sup>†</sup>, Zhang, J., Shu, L. and Gu, Y. (2025). <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/sim.70196" target="_blank">An Integrated and Coherent Framework for Point Estimation and Hypothesis Testing with Concurrent Controls in Platform Trials</a>. <em>Statistics in Medicine</em>, 44(15-17), e70196.
<br>
<br>
<strong>Zhan, T.</strong><sup>†</sup> and, Gu, Y. (2025). <a href="https://www.tandfonline.com/doi/abs/10.1080/10618600.2025.2507428" target="_blank">Semiparametric Weighted Spline Regression (SWSR) in Confirmatory Clinical Trials with Time-Varying Placebo Effects</a>. <em>Journal of Computational and Graphical Statistics</em>.
<br>
<br>
<strong>Zhan, T.</strong><sup>†</sup> and Kang, J.<sup>†</sup> (2025). <a href="https://academic.oup.com/biometrics/article-abstract/81/1/ujaf014/8051005" target="_blank">A general, flexible and harmonious framework to construct interpretable functions in regression analysis</a>. <em>Biometrics</em>, (81)1, ujaf014.
<br>
<br>
<strong>Zhan, T.</strong><sup>†</sup> (2024). <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/sim.10041" target="_blank">A class of computational methods to reduce selection bias when designing Phase 3 clinical trials</a>. <em>Statistics in Medicine</em>, 43(10), 1993-2006.
<br>
<br>
<strong>Zhan, T.</strong><sup>†</sup>, Fu, H. and Kang, J. (2024). <a href="https://www.tandfonline.com/doi/full/10.1080/19466315.2023.2260776" target="_blank">Deep Neural Networks Guided Ensemble Learning for Point Estimation</a>. <em>Statistics in Biopharmaceutical Research</em>, 16(2), 270-278.
<br>
<br>
<strong>Zhan, T.</strong><sup>†</sup> (2022). <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/sim.9564" target="_blank">DL 101: Basic introduction to deep learning with its application in biomedical related fields</a>. <em>Statistics in Medicine</em>, 41 (26), 5365-5378.
<br>
<br>
Li Y.<sup>†</sup>, Feng D., Sui Y., Li H., Song Y., <strong>Zhan, T.</strong>, Cicconetti G., Jin M., Wang H., Chan I. and Wang X. (2022). <a href="https://www.sciencedirect.com/science/article/abs/pii/S155171442200043X" target="_blank">Analyzing longitudinal binary data in clinical studies</a>. <em>Contemporary Clinical Trials</em>, 106717.
<br>
<br>
<strong>Zhan, T.</strong><sup>†</sup> and Kang, J. (2022). <a href="https://www.tandfonline.com/doi/full/10.1080/10618600.2021.2020128" target="_blank">Finite-Sample Two-Group Composite Hypothesis Testing via Machine Learning</a>. <em>Journal of Computational and Graphical Statistics</em>, 31(3), 856-865.
<br>
<br>
<strong>Zhan, T.</strong><sup>†</sup>, Hartford, A., Kang, J. and Offen, W. (2022). <a href="https://www.tandfonline.com/doi/full/10.1080/19466315.2020.1799855" target="_blank">Optimizing Graphical Procedures for Multiplicity Control in a Confirmatory Clinical Trial via Deep Learning</a>. <em>Statistics in Biopharmaceutical Research</em>, 14(1), 92-102.
<br>
<br>
<strong>Zhan, T.</strong><sup>†</sup>, Zhou, Y., Geng, Z., Gu, Y., Kang, J., Wang, L., Huang X. and Slate, E. H. (2021). <a href="https://www.tandfonline.com/doi/full/10.1080/10543406.2021.1975128" target="_blank">Deep Historical Borrowing Framework to Prospectively and Simultaneously Synthesize Control Information in Confirmatory Clinical Trials with Multiple Endpoints</a>. <em>Journal of Biopharmaceutical Statistics</em>, 32 (1), 90-106.
<br>
<br>
<strong>Zhan, T.</strong><sup>†</sup>, Cui, L., Geng, Z., Zhang, L., Gu, Y. and Chan, I. S. (2021). <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/sim.9104" target="_blank">A Practical Response Adaptive Block Randomization (RABR) Design with Analytic Type I Error Protection</a>. <em>Statistics in Medicine</em>, 40(23), 4947-4960.
<br>
<br>
Cui, L.<sup>†</sup>, <strong>Zhan, T.</strong>, Zhang, L., Geng, Z., Gu, Y. and Chan, I.S. (2021). <a href="https://journals.sagepub.com/doi/10.1177/0962280220984822" target="_blank">An automation-based adaptive seamless design for dose selection and confirmation with improved power and efficiency</a>. <em>Statistical Methods in Medical Research</em>, 30(4), 1013-1025.
<br>
<br>
<strong>Zhan, T.</strong> and Schaubel, D. E.<sup>†</sup> (2020). <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/cjs.11528" target="_blank">Semiparametric regression methods for temporal processes subject to multiple sources of censoring</a>. <em>Canadian Journal of Statistics</em>, 48(2), 222-237.
<br>
<br>
<strong>Zhan, T.</strong><sup>†</sup>, Zhang, H., Hartford, A. and Mukhopadhyay, S. (2020). <a href="https://www.tandfonline.com/doi/full/10.1080/10543406.2020.1744620" target="_blank">Modified Goldilocks Design with strict type I error control in confirmatory clinical trials</a>. <em>Journal of Biopharmaceutical Statistics</em>, 30(5), 821-833.
<br>
<br>
<strong>Zhan, T.</strong> and Schaubel, D. E.<sup>†</sup> (2019). <a href="https://link.springer.com/article/10.1007/s10985-018-9433-8" target="_blank">Semiparametric temporal process regression of survival-out-of-hospital</a>. <em>Lifetime Data Analysis</em>, 25(2), 322-340.
<br>
<br>
Jiang, H.<sup>†</sup> and <strong>Zhan, T.</strong> (2017). <a href="https://link.springer.com/article/10.1007/s12561-016-9182-8" target="_blank">Unit-free and robust detection of differential expression from RNA-Seq data</a>. <em>Statistics in Biosciences</em>, 9(1), 178-199.
<br>
<br>
<strong> Peer-reviewed Medical Articles: </strong>
<br>
<br>
Ackerman, L.S., Schlosser, B.J., <strong>Zhan, T.</strong>, Prajapati, V.H., Fretzin, S., Takahashi, H., Huang, X., Camp, H.S. and Kimball, A.B.<sup>†</sup> (2025). <a href="https://www.jaad.org/article/S0190-9622(25)00190-2/fulltext" target="_blank">Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled study</a>. <em>Journal of the American Academy of Dermatology</em>, 92(6), 1252-1260.
<br>
<br>
Lebwohl, M.<sup>†</sup>, Bukhalo, M., Gold, L.S., Glick, B., Llamas-Velasco, M., Sanchez-Rivera, S., Pan, A., <strong>Zhan, T.</strong>, Drogaris, L., Douglas, K. and John, G.S. (2024). <a href="https://www.jaad.org/article/S0190-9622(24)02747-6/fulltext" target="_blank">A randomized phase 3b study evaluating the safety and efficacy of risankizumab in adult patients with moderate-to-severe plaque psoriasis with non-pustular palmoplantar involvement</a>. <em>Journal of the American Academy of Dermatology</em>, 91 (6), 1150-1157 .
<br>
<br>
Strober, B.<sup>†</sup>, Bachelez, H., Crowley, J., Elewski, B.E., Gooderham, M., Menter, A., Strohal, R., Chen, M.M., Wu, T., <strong>Zhan, T.</strong> and Photowala, H. (2024). <a href="https://onlinelibrary.wiley.com/doi/10.1111/jdv.19748" target="_blank">Efficacy of long‐term risankizumab treatment for moderate‐to‐severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial)</a>. <em>Journal of the European Academy of Dermatology and Venereology</em>, 38(5), 864-872.
<br>
<br>
Kimball, A.B.<sup>†</sup>, Prens, E.P., Passeron, T., Maverakis, E., Turchin, I., Beeck, S., Drogaris, L., Geng, Z., <strong>Zhan, T.</strong>, Messina, I. and Bechara, F.G. (2023). <a href="https://link.springer.com/article/10.1007/s13555-023-00913-3" target="_blank">Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial</a>. <em>Dermatology and Therapy</em>, 13(5), 1099-1111.
<br>
<br>
Gooderham, M.<sup>†</sup>, Pinter, A., Ferris, L.K., Warren, R.B., <strong>Zhan, T.</strong>, Zeng, J., Soliman, A.M., Kaufmann, C., Kaplan, B., Photowala, H. and Strober, B. (2022). <a href="https://onlinelibrary.wiley.com/doi/10.1111/jdv.18010" target="_blank">Long-term, durable, absolute Psoriasis Area and Severity Index and health-related quality of life improvements with risankizumab treatment: a post-hoc integrated analysis of patients with moderate-to-severe plaque psoriasis</a>. <em>Journal of the European Academy of Dermatology and Venereology</em>, 36(6), 855-865.
<br>
<br>
Crowley, J.J.<sup>†</sup>, Langley, R.G., Gordon, K.B., Pinter, A., Ferris, L.K., Rubant, S., Photowala, H., Xue, Z., Wu, T., <strong>Zhan, T.</strong> and Beeck, S. (2022). <a href="https://link.springer.com/article/10.1007/s13555-021-00679-6" target="_blank">Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge Study</a>. <em>Dermatology and Therapy</em>, 12(2), 561-575.
<br>
<br>
Blauvelt, A.<sup>†</sup>, Gordon, K.B., Lee, P., Bagel, J., Sofen, H., Lockshin, B., Soliman, A.M., Geng, Z., <strong>Zhan, T.</strong>, Alperovich, G. and Stein Gold, L. (2021). <a href="https://www.tandfonline.com/doi/full/10.1080/09546634.2021.1914812" target="_blank">Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis</a>. <em>Journal of Dermatological Treatment</em>, 33 (4), 2085-2093.
<br>
<br>
Strober, B.<sup>†</sup>, Menter, A., Leonardi, C., Gordon, K., Lambert, J., Puig, L., Photowala, H., Longcore, M., <strong>Zhan, T.</strong> and Foley, P. (2020). <a href="https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.16521" target="_blank">Efficacy of Risankizumab in Patients with Moderate-to-Severe Plaque Psoriasis by Baseline Demographics, Disease Characteristics and Prior Biologic Therapy: An Integrated Analysis of the Phase III UltIMMa-1 and UltIMMa-2 Studies</a>. <em>Journal of the European Academy of Dermatology and Venereology</em>, 34(12), 2830-2838.
<br>
<br>
McDaniel, A. S., Alva, A., <strong>Zhan, T.</strong>, Xiao, H., Cao, X., Gursky, A., Siddiqui, J., Chinnaiyan, A.M., Jiang, H., Lee, C.T. and Mehra, R.<sup>†</sup> (2016). <a href="https://www.sciencedirect.com/science/article/abs/pii/S2405456915000255" target="_blank">Expression of PDL1 (B7-H1) before and after neoadjuvant chemotherapy in urothelial carcinoma</a>. <em>European Urology Focus</em>, 1(3), 265-268.
<br>
<br>
Magers, M. J., <strong>Zhan, T.</strong>, Udager, A. M., Wei, J. T., Tomlins, S. A., Wu, A. J., Kunju, L.P., Lew, M., Feng, F.Y., Hamstra, D.A., Siddiqui, J., Chinnaiyan, A.M., Montgomery J.S., Weizer, A.Z., Morgan, T.M., Hollenbeck, B.K., Miller, D.C., Palapattu, G.S., Jiang, H. and Mehra, R.<sup>†</sup> (2015). <a href="https://link.springer.com/article/10.1007/s12032-015-0693-9" target="_blank">Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology</a>. <em>Medical Oncology</em>, 32(11), 249.





